J&J Suffers Headache Over Migraine Generic

Law360, New York (October 19, 2005, 12:00 AM EDT) -- Johnson & Johnson has sued a Canadian generics drug maker in federal court, asserting its patent for a widely-used treatment for migraine headaches.

New Jersey-based Ortho-McNeil Pharmaceutical Inc., part of the J&J group of companies, sued Ontario-based Cobalt Pharmaceutical Inc. this month in the U.S. District Court for the District of New Jersey. It seeks to protect from generic reproduction its drug Topamax, which is also used to prevent seizures.

The patent, entitled “anticonvulsant sulfamate derivatives” was issued to inventors at McNeil Labs Inc., a corporate...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.